title: [Voluntary abortion: new perspectives in local anesthesia].
abstract: New perspectives have been envisioned for the TOP instrumental technique, through the utilization of pharmacologic products, whose property is to dilatate the cervix. Misoprostol or mifepristone, when administrated to a patient a few hours before a TOP by uterine suction curettage, enables a dilatation of the cervix in such a way that it allows the surgically induced abortion to be carried out with local anesthesia, under optimal comfort conditions for the patients as well as for the operator.
authors.affiliation: Centre de planification et d'interruption volontaire de grossesse, Hôpital de la Fraternité, Roubaix.
authors.forename: P
authors.initials: P
authors.lastname: Lefebvre
authors.forename: N
authors.initials: N
authors.lastname: Monniez
authors.forename: G
authors.initials: G
authors.lastname: Norel
authors.forename: D
authors.initials: D
authors.lastname: Prévost
authors.forename: W
authors.initials: W
authors.lastname: Scharfman
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced / Q000379:methods*; D000772:Anesthesia, Local / Q000379:methods* / Q000639:trends*; D006801:Humans; D015735:Mifepristone; D016595:Misoprostol
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone
vernacular_title: Interruption volontaire de grossesse: nouvelles perspectives de l'anesthésie locale.